MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ADXS
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Ayala Pharmaceuticals (ADXS) Ownership - Who owns Ayala Pharmaceuticals?

Ayala Pharmaceuticals Inc is a clinical-stage oncology company whose primary clinical assets currently include aspacytarabine (BST-236), a novel proprietary anti-metabolite for first-line treatment in unfit acute myeloid leukemia (AML)... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
Oppenheimer 4
Phone
+972 8574440553
Employees
35
Web
https://www.ayalapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.48M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.52
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ADXS
A.I. Advisor
published General Information

General Information

a developer of immunotherapies for cancer and infectious diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
Oppenheimer 4
Phone
+972 8574440553
Employees
35
Web
https://www.ayalapharma.com